Instylla
Setting a new standard for selectivity, ease, and efficacy for embolization therapy in interventional radiology and oncology.
Launch date
Employees
Market cap
-
Enterprise valuation
$120—180m (Dealroom.co estimates Aug 2023.)
Waltham Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $8.1m | Early VC | |
$25.4m | Series B | ||
* | $30.0m | Late VC | |
Total Funding | $63.5m |
Recent News about Instylla
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.